News

Growth stocks fell hard over the past couple of years. Equity markets have been kinder to them in 2023, but many remain firmly in the red compared to their mid-2021 levels. While it isn't ideal

Nucor (NYSE: NUE) is one of the best-run steel mills in North America -- and, perhaps, the world. There are some nuances in that statement that investors need to understand. One of the most

Shares of drug manufacturer Emergent BioSolutions (NYSE: EBS) are down 75% in the past 12 months. Investors have been turning to safer investments amid the bear market and ditching the risky

The cannabis industry appears to have lost steam in recent years. The industry's enthusiasm is low because there has been little progress toward federal legalization. However, the industry as a

Nucor (NYSE: NUE) is a very well-run company. This is highlighted by the fact that it has increased its dividend annually for 50 consecutive years. That's even more notable because it operates in

Investor optimism is back as several growth stocks that had an abysmal year in 2022 are making new 52-week highs. Yet many risk-averse investors may prefer to not chase the hype and instead focus on

Cannabis investing is a long-term game. Savvy investors understand that investing in cannabis stocks requires a high tolerance for risk. Cannabis stocks performed poorly in 2022, and this year has

The following three international companies have great exposure to exciting growth trends and each has shares traded as American depositary receipts (ADRs). This makes it easy for investors to buy

The cannabis industry doesn't look as enticing to investors as it did a few years ago. In recent years, it has struggled, owing primarily to a lack of progress toward federal legalization. Even if

Image source: The Motley Fool.

Tencent (OTC: TCEHY)Q1 2023 Earnings CallMay 17, 2023, 8:00 a.m. ET

Wendy Huang

Continue reading

Source Fool.com

The marijuana industry is currently very interesting. While the majority of marijuana stocks are declining, affected by a lack of progress toward legalization, the sector as a whole is expanding

It has essentially become a fact that cannabis stocks are among the riskiest investments due to the illicit nature of the industry in many countries. Investors seemingly agreed, with the

Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7 billion by Swedish Orphan Biovitrum AB (OTC: BIOVF), also